デフォルト表紙
市場調査レポート
商品コード
1537055

医療用手袋市場:世界の産業分析、規模、シェア、成長、動向、予測、2024年~2032年

Medical Gloves Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032


出版日
ページ情報
英文 250 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
医療用手袋市場:世界の産業分析、規模、シェア、成長、動向、予測、2024年~2032年
出版日: 2024年08月13日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界の医療用手袋市場に関する包括的なレポートを発表しました。当レポートでは、促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察:医療用手袋市場

  • 市場規模(2024年):1,090万米ドル
  • 市場予測金額(2032年):1,760万米ドル
  • 世界市場成長率(CAGR 2024年~2032年):6.2%

医療用手袋市場 - 調査範囲

医療用手袋は、病院、診療所、外来手術センターなど、さまざまな医療現場で衛生と安全を維持する上で重要な役割を果たしています。これらの手袋は、ヘルスケアプロバイダーと患者間の二次汚染を防止し、感染症のリスクを低減するために不可欠です。医療用手袋市場には、ラテックス、ニトリル、ビニール、ネオプレンなどさまざまなタイプの手袋があり、材料の好み、アレルギー、特定の医療用途に基づくさまざまな要件に対応しています。

市場成長の促進要因

世界の医療用手袋市場は、ヘルスケア従事者の衛生と安全に対する意識の高まり、院内感染(HAI)の発生率の上昇、快適性と耐久性を高めた優れた品質の手袋に対する需要の高まりなど、いくつかの主要な要因によって推進されています。さらに、COVID-19の大流行は、個人防護具(PPE)の重要な構成要素としての医療用手袋の需要を大幅に押し上げました。パウダーフリーや低アレルギー性手袋の開発など、手袋製造における技術的進歩は、ユーザーのニーズや規制要件に対応することで、市場の成長をさらに後押ししています。

市場抑制要因

有望な成長見通しにもかかわらず、医療用手袋市場は原材料価格の変動、サプライチェーンの混乱、使用済み手袋の廃棄に伴う環境問題などに関連する課題に直面しています。特にラテックスとニトリルの原材料価格の変動は、生産コストと利益率に影響を与えます。COVID-19の大流行によって悪化したサプライチェーンの混乱も、急増する需要を満たす上での課題となっています。さらに、医療廃棄物の原因となる使い捨て手袋の環境への影響から、持続可能な解決策と生分解性手袋材料の革新が求められています。

市場機会

医療用手袋市場は、ヘルスケア支出の増加、ヘルスケア・インフラの拡大、感染予防・管理への関心の高まりによって大きな成長機会をもたらしています。自動化やロボット工学などの高度な製造技術の採用により、生産効率と製品品質が向上しています。さらに、持続可能で環境に優しい医療製品に対する動向の高まりは、生分解性でリサイクル可能な手袋の開発と採用を後押ししています。戦略的パートナーシップ、M&A、研究開発への投資は、新たなビジネスチャンスを活用し、ダイナミックな医療用手袋市場においてリーダーシップを維持するために不可欠です。

本レポートで扱う主要な質問

  • 世界の医療用手袋市場の成長を促す主要な要因は何か?
  • 様々なヘルスケアシーンで医療用手袋の採用を促進している手袋の種類と用途は何か?
  • 技術の進歩は医療用手袋市場の競合情勢をどのように変えているのか?
  • 医療用手袋市場に貢献している主要企業はどこで、市場の関連性を維持するためにどのような戦略を採用しているのか?
  • 世界の医療用手袋市場における新たな動向と将来性は?

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション / 開発動向

第4章 主要な成功要因

  • 規制状況
  • 主要なプロモーション戦略:市場企業別
  • PESTEL分析
  • ポーターの分析
  • 製品採用分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 収益:製品別
    • 収益:エンドユーザー別
    • 収益:国別
  • 2024年の市場シナリオ

第7章 世界市場 - 価格分析

  • 地域別価格分析:製品別
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク

第8章 世界市場の需要(数量、単位)分析

  • 過去の市場数量(単位)分析、2019年~2023年
  • 現在および将来の市場数量(単位)予測、2024年~2032年
    • 前年比成長動向分析

第9章 世界市場の需要(金額または規模、百万米ドル)分析

  • 過去の市場金額(百万米ドル)分析、2019年~2023年
  • 現在および将来の市場金額(百万米ドル)予測、2024年~2032年
    • 前年比成長動向分析
    • 絶対額の機会分析

第10章 世界市場分析:製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模(百万米ドル)の分析:製品別、2019年~2023年
  • 現在および将来の市場規模(百万米ドル)分析と予測:製品別、2024年~2032年
    • 再利用可能な手袋
    • 使い捨て検査用手袋
    • 手術用手袋
    • 使い捨て産業用手袋
  • 市場の魅力分析:製品別

第11章 世界市場分析:エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模(百万米ドル)の分析:エンドユーザー別、2019年~2023年
  • 現在および将来の市場規模(百万米ドル)の分析と予測:エンドユーザー別、2024年~2032年
    • 医療分野
    • 非医療分野
  • 市場の魅力分析:エンドユーザー別

第12章 世界分析:地域別

  • イントロダクション
  • 過去の市場規模(百万米ドル)の分析:地域別、2019年~2023年
  • 現在および将来の市場規模(百万米ドル)の分析と予測:地域別、2024年~2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ(MEA)
  • 市場の魅力分析:地域別

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 東アジア市場分析

第17章 南アジア市場分析

第18章 オセアニア市場分析

第19章 中東・アフリカ(MEA)市場分析

第20章 市場構造分析

  • 市場分析:企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合の詳細情報
    • Top Glove Corporation Bhd
    • Ansell
    • Hartalega Holdings Berhad
    • Supermax Corporation Berhad
    • Kossan Rubber Industries Bhd
    • Semperit AG Holding
    • Rubberex Corporation(M)Bhd
    • Comfort Rubber Gloves Industries Sdn Bhd
    • Cardinal Health, Inc.
    • B. Braun Melsungen AG
    • Riverstone Holdings Limited
    • Brightway Holdings Sdn. Bhd
    • Dynarex Corporation
    • WRP Asia Pacific Sdn Bhd
    • Alliance Rubber Products Sdn Bhd
    • Qube Medical Products Sdn Bhd
    • Healthy Glove Co., Ltd
    • Sri Trang Agro-Industry Plc.
    • Medisafe Technologies
    • Delta Gloves

第22章 使用される前提条件と頭字語

第23章 調査手法

目次
Product Code: PMRREP4647

Persistence Market Research has recently released a comprehensive report on the worldwide market for medical gloves. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Medical Gloves Market

  • Market Size (2024E): USD 10.9 Million
  • Projected Market Value (2032F): USD 17.6 Million
  • Global Market Growth Rate (CAGR 2024 to 2032): 6.2%

Medical Gloves Market - Report Scope

Medical gloves play a crucial role in maintaining hygiene and safety in various medical settings, including hospitals, clinics, and ambulatory surgical centers. These gloves are essential in preventing cross-contamination between healthcare providers and patients, thereby reducing the risk of infections. The medical gloves market offers a range of glove types, including latex, nitrile, vinyl, and neoprene gloves, catering to different requirements based on material preferences, allergies, and specific medical applications.

Market Growth Drivers

The global medical gloves market is propelled by several key factors, including the increasing awareness about hygiene and safety among healthcare providers, the rising incidence of hospital-acquired infections (HAIs), and the growing demand for superior-quality gloves with enhanced comfort and durability. Additionally, the COVID-19 pandemic has significantly boosted the demand for medical gloves as a critical component of personal protective equipment (PPE). Technological advancements in glove manufacturing, such as the development of powder-free and hypoallergenic gloves, further drive market growth by addressing user needs and regulatory requirements.

Market Restraints

Despite promising growth prospects, the medical gloves market faces challenges related to raw material price volatility, supply chain disruptions, and environmental concerns associated with the disposal of used gloves. The fluctuations in raw material prices, particularly for latex and nitrile, impact production costs and profit margins. Supply chain disruptions, exacerbated by the COVID-19 pandemic, have also posed challenges in meeting the surging demand. Furthermore, the environmental impact of disposable gloves, which contribute to medical waste, calls for sustainable solutions and innovations in biodegradable glove materials.

Market Opportunities

The medical gloves market presents significant growth opportunities driven by increasing healthcare expenditure, expanding healthcare infrastructure, and the rising focus on infection prevention and control. The adoption of advanced manufacturing technologies, such as automation and robotics, enhances production efficiency and product quality. Moreover, the growing trend towards sustainable and eco-friendly medical products encourages the development and adoption of biodegradable and recyclable gloves. Strategic partnerships, mergers and acquisitions, and investment in research and development are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic medical gloves landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the medical gloves market globally?
  • Which glove types and applications are driving the adoption of medical gloves across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the medical gloves market?
  • Who are the key players contributing to the medical gloves market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global medical gloves market?

Competitive Intelligence and Business Strategy

Leading players in the global medical gloves market, including Ansell Limited, Top Glove Corporation Bhd, Hartalega Holdings Berhad, and Cardinal Health, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced glove solutions, including antimicrobial gloves, double-gloving systems, and hypoallergenic gloves, catering to diverse user needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and user education fosters market growth and enhances patient safety and outcomes in the rapidly evolving medical gloves landscape.

Key Companies Profiled:

  • Top Glove Corporation Bhd
  • Ansell
  • Hartalega Holdings Berhad
  • Supermax Corporation Berhad
  • Kossan Rubber Industries Bhd
  • Semperit AG Holding
  • Rubberex Corporation (M) Bhd
  • Comfort Rubber Gloves Industries Sdn Bhd
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • Riverstone Holdings Limited
  • Brightway Holdings Sdn. Bhd
  • Dynarex Corporation
  • WRP Asia Pacific Sdn Bhd
  • Alliance Rubber Products Sdn Bhd
  • Qube Medical Products Sdn Bhd
  • Healthy Glove Co., Ltd
  • Sri Trang Agro-Industry Plc.
  • Medisafe Technologies
  • Delta Gloves

Medical Gloves Industry Research Segmentation

By Product:

  • Reusable Gloves
  • Disposable Examination Gloves
  • Surgical Gloves
  • Disposable Industrial Gloves

By End User:

  • Medical Sector
  • Non-Medical Sector

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Regulatory Landscape
  • 4.2. Key Promotional Strategies, by Market Players
  • 4.3. PESTEL Analysis
  • 4.4. Porter's Analysis
  • 4.5. Product Adoption Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Surgery Volumes
    • 5.2.2. Rise in R&D Activities
    • 5.2.3. Rising prevalence of infectious diseases
    • 5.2.4. GDP growth
    • 5.2.5. Increase awareness about hygiene among healthcare professionals
    • 5.2.6. Historic Growth of Market players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Product
    • 6.1.2. Revenue By End User
    • 6.1.3. Revenue By Country
  • 6.2. 2024 Market Scenario

7. Global Market - Pricing Analysis

  • 7.1. Regional Pricing Analysis By Product
  • 7.2. Pricing Break-up
    • 7.2.1. Manufacturer Level Pricing
    • 7.2.2. Distributor Level Pricing
  • 7.3. Global Average Pricing Analysis Benchmark

8. Global Market Demand (Volume in units) Analysis 2019-2023 and Forecast, 2024-2032

  • 8.1. Historical Market Volume (in units) Analysis, 2019-2023
  • 8.2. Current and Future Market Volume (in units) Projections, 2024-2032
    • 8.2.1. Y-o-Y Growth Trend Analysis

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 10.3.1. Reusable Gloves
      • 10.3.1.1. Fabric-Supported Gloves
        • 10.3.1.1.1. Natural Rubber (NR)
        • 10.3.1.1.2. Nitrile Rubber (NBR)
        • 10.3.1.1.3. Polyvinyl chloride (PVC)
        • 10.3.1.1.4. Polyurethane (PU)
      • 10.3.1.2. Industrial & Household Gloves
        • 10.3.1.2.1. Natural Rubber (NR)
        • 10.3.1.2.2. Nitrile Rubber (NBR)
        • 10.3.1.2.3. Neoprene
        • 10.3.1.2.4. Polyvinyl chloride (PVC)
    • 10.3.2. Disposable Examination Gloves
      • 10.3.2.1. Natural Rubber (NR)
        • 10.3.2.1.1. Powdered Gloves
        • 10.3.2.1.2. Non Powdered Gloves
      • 10.3.2.2. Nitride Rubber (NBR)
      • 10.3.2.3. Polyvinyl Chloride (PVC)
    • 10.3.3. Surgical Gloves
      • 10.3.3.1. Natural Rubber (NR)
        • 10.3.3.1.1. Powdered Gloves
        • 10.3.3.1.2. Non powdered Gloves
      • 10.3.3.2. Synthetic
      • 10.3.3.3. Chloroprene
      • 10.3.3.4. Isoprene
    • 10.3.4. Disposable Industrial Gloves
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
    • 11.3.1. Medical Sector
      • 11.3.1.1. Acute Care
      • 11.3.1.2. Laboratory Services
      • 11.3.1.3. Research Services
    • 11.3.2. Non-Medical Sector
      • 11.3.2.1. Food Processing
      • 11.3.2.2. Commercial Manufacturing
      • 11.3.2.3. Cleanroom Application
      • 11.3.2.4. Household Application
  • 11.4. Market Attractiveness Analysis By End User

12. Global Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Market Trends
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By End User
    • 13.8.2. Canada Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Market Trends
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
    • 14.8.2. Brazil Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
    • 14.8.3. Argentina Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. UK
      • 15.3.1.2. Germany
      • 15.3.1.3. Italy
      • 15.3.1.4. Italy.
      • 15.3.1.5. France
      • 15.3.1.6. Spain
      • 15.3.1.7. Russia
      • 15.3.1.8. BENELUX
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Market Trends
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. UK Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
    • 15.8.2. Germany Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
    • 15.8.3. Italy Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User
    • 15.8.4. France Market
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By End User
    • 15.8.5. Spain Market
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By End User
    • 15.8.6. Russia Market
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By End User
    • 15.8.7. BENELUX Market
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Market Trends
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
    • 16.8.2. Japan Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User
    • 16.8.3. South Korea Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Market Trends
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
    • 17.8.2. Indonesia Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
    • 17.8.3. Malaysia Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User
    • 17.8.4. Thailand Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By End User

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By End User
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By End User
    • 18.8.2. New Zealand Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Market Trends
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By End User
    • 19.8.2. Turkiye Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By End User
    • 19.8.3. South Africa Market
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By End User
    • 19.8.4. North Africa Market
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis
    • 20.3.1. Regional footprint of Players
    • 20.3.2. Platform Type foot print by Players
    • 20.3.3. Channel Foot Print by Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Deep Dive
    • 21.2.1. Top Glove Corporation Bhd
      • 21.2.1.1. Overview & Key financials
      • 21.2.1.2. R& D Expenditure
      • 21.2.1.3. Sales Footprint
      • 21.2.1.4. Strategy Overview
        • 21.2.1.4.1. Marketing Strategy
        • 21.2.1.4.2. Drug Strategy
        • 21.2.1.4.3. Channel Strategy
    • 21.2.2. Ansell
      • 21.2.2.1. Overview & Key financials
      • 21.2.2.2. R& D Expenditure
      • 21.2.2.3. Sales Footprint
      • 21.2.2.4. Strategy Overview
        • 21.2.2.4.1. Marketing Strategy
        • 21.2.2.4.2. Drug Strategy
        • 21.2.2.4.3. Channel Strategy
    • 21.2.3. Hartalega Holdings Berhad
      • 21.2.3.1. Overview & Key financials
      • 21.2.3.2. R& D Expenditure
      • 21.2.3.3. Sales Footprint
      • 21.2.3.4. Strategy Overview
        • 21.2.3.4.1. Marketing Strategy
        • 21.2.3.4.2. Drug Strategy
        • 21.2.3.4.3. Channel Strategy
    • 21.2.4. Supermax Corporation Berhad
      • 21.2.4.1. Overview & Key financials
      • 21.2.4.2. R& D Expenditure
      • 21.2.4.3. Sales Footprint
      • 21.2.4.4. Strategy Overview
        • 21.2.4.4.1. Marketing Strategy
        • 21.2.4.4.2. Drug Strategy
        • 21.2.4.4.3. Channel Strategy
    • 21.2.5. Kossan Rubber Industries Bhd
      • 21.2.5.1. Overview & Key financials
      • 21.2.5.2. R& D Expenditure
      • 21.2.5.3. Sales Footprint
      • 21.2.5.4. Strategy Overview
        • 21.2.5.4.1. Marketing Strategy
        • 21.2.5.4.2. Drug Strategy
        • 21.2.5.4.3. Channel Strategy
    • 21.2.6. Semperit AG Holding
      • 21.2.6.1. Overview & Key financials
      • 21.2.6.2. R& D Expenditure
      • 21.2.6.3. Sales Footprint
      • 21.2.6.4. Strategy Overview
        • 21.2.6.4.1. Marketing Strategy
        • 21.2.6.4.2. Drug Strategy
        • 21.2.6.4.3. Channel Strategy
    • 21.2.7. Rubberex Corporation (M) Bhd
      • 21.2.7.1. Overview & Key financials
      • 21.2.7.2. R& D Expenditure
      • 21.2.7.3. Sales Footprint
      • 21.2.7.4. Strategy Overview
        • 21.2.7.4.1. Marketing Strategy
        • 21.2.7.4.2. Drug Strategy
        • 21.2.7.4.3. Channel Strategy
    • 21.2.8. Comfort Rubber Gloves Industries Sdn Bhd
      • 21.2.8.1. Overview & Key financials
      • 21.2.8.2. R& D Expenditure
      • 21.2.8.3. Sales Footprint
      • 21.2.8.4. Strategy Overview
        • 21.2.8.4.1. Marketing Strategy
        • 21.2.8.4.2. Drug Strategy
        • 21.2.8.4.3. Channel Strategy
    • 21.2.9. Cardinal Health, Inc.
      • 21.2.9.1. Overview & Key financials
      • 21.2.9.2. R& D Expenditure
      • 21.2.9.3. Sales Footprint
      • 21.2.9.4. Strategy Overview
        • 21.2.9.4.1. Marketing Strategy
        • 21.2.9.4.2. Drug Strategy
        • 21.2.9.4.3. Channel Strategy
    • 21.2.10. B. Braun Melsungen AG
      • 21.2.10.1. Overview & Key financials
      • 21.2.10.2. R& D Expenditure
      • 21.2.10.3. Sales Footprint
      • 21.2.10.4. Strategy Overview
        • 21.2.10.4.1. Marketing Strategy
        • 21.2.10.4.2. Drug Strategy
        • 21.2.10.4.3. Channel Strategy
    • 21.2.11. Riverstone Holdings Limited
      • 21.2.11.1. Overview & Key financials
      • 21.2.11.2. R& D Expenditure
      • 21.2.11.3. Sales Footprint
      • 21.2.11.4. Strategy Overview
        • 21.2.11.4.1. Marketing Strategy
        • 21.2.11.4.2. Drug Strategy
        • 21.2.11.4.3. Channel Strategy
    • 21.2.12. Brightway Holdings Sdn. Bhd
      • 21.2.12.1. Overview & Key financials
      • 21.2.12.2. R& D Expenditure
      • 21.2.12.3. Sales Footprint
      • 21.2.12.4. Strategy Overview
        • 21.2.12.4.1. Marketing Strategy
        • 21.2.12.4.2. Drug Strategy
        • 21.2.12.4.3. Channel Strategy
    • 21.2.13. Dynarex Corporation
      • 21.2.13.1. Overview & Key financials
      • 21.2.13.2. R& D Expenditure
      • 21.2.13.3. Sales Footprint
      • 21.2.13.4. Strategy Overview
        • 21.2.13.4.1. Marketing Strategy
        • 21.2.13.4.2. Drug Strategy
        • 21.2.13.4.3. Channel Strategy
    • 21.2.14. WRP Asia Pacific Sdn Bhd
      • 21.2.14.1. Overview & Key financials
      • 21.2.14.2. R& D Expenditure
      • 21.2.14.3. Sales Footprint
      • 21.2.14.4. Strategy Overview
        • 21.2.14.4.1. Marketing Strategy
        • 21.2.14.4.2. Drug Strategy
        • 21.2.14.4.3. Channel Strategy
    • 21.2.15. Alliance Rubber Products Sdn Bhd
      • 21.2.15.1. Overview & Key financials
      • 21.2.15.2. R& D Expenditure
      • 21.2.15.3. Sales Footprint
      • 21.2.15.4. Strategy Overview
        • 21.2.15.4.1. Marketing Strategy
        • 21.2.15.4.2. Drug Strategy
        • 21.2.15.4.3. Channel Strategy
    • 21.2.16. Qube Medical Products Sdn Bhd
      • 21.2.16.1. Overview & Key financials
      • 21.2.16.2. R& D Expenditure
      • 21.2.16.3. Sales Footprint
      • 21.2.16.4. Strategy Overview
        • 21.2.16.4.1. Marketing Strategy
        • 21.2.16.4.2. Drug Strategy
        • 21.2.16.4.3. Channel Strategy
    • 21.2.17. Healthy Glove Co., Ltd
      • 21.2.17.1. Overview & Key financials
      • 21.2.17.2. R& D Expenditure
      • 21.2.17.3. Sales Footprint
      • 21.2.17.4. Strategy Overview
        • 21.2.17.4.1. Marketing Strategy
        • 21.2.17.4.2. Drug Strategy
        • 21.2.17.4.3. Channel Strategy
    • 21.2.18. Sri Trang Agro-Industry Plc.
      • 21.2.18.1. Overview & Key financials
      • 21.2.18.2. R& D Expenditure
      • 21.2.18.3. Sales Footprint
      • 21.2.18.4. Strategy Overview
        • 21.2.18.4.1. Marketing Strategy
        • 21.2.18.4.2. Drug Strategy
        • 21.2.18.4.3. Channel Strategy
    • 21.2.19. Medisafe Technologies
      • 21.2.19.1. Overview & Key financials
      • 21.2.19.2. R& D Expenditure
      • 21.2.19.3. Sales Footprint
      • 21.2.19.4. Strategy Overview
        • 21.2.19.4.1. Marketing Strategy
        • 21.2.19.4.2. Drug Strategy
        • 21.2.19.4.3. Channel Strategy
    • 21.2.20. Delta Gloves
      • 21.2.20.1. Overview & Key financials
      • 21.2.20.2. R& D Expenditure
      • 21.2.20.3. Sales Footprint
      • 21.2.20.4. Strategy Overview
        • 21.2.20.4.1. Marketing Strategy
        • 21.2.20.4.2. Drug Strategy
        • 21.2.20.4.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology